v3.26.1
Revenue Recognition - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended
Nov. 30, 2023
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Aug. 30, 2024
Disaggregation of Revenue [Line Items]          
Revenue from contract with customers excluding assessed tax   $ 348,116 $ 255,737    
Contract with customer liability amount of revenue recognized that was included in the opening balance   35,100 26,900    
Accounts Receivable [Member]          
Disaggregation of Revenue [Line Items]          
Contract with customer receivable after allowance for credit loss current   24,500   $ 8,100  
Long-Term Contract with Customer [Member]          
Disaggregation of Revenue [Line Items]          
Revenue, remaining performance obligation   378,400      
Commercialization and Reference Laboratory Agreement Member With Personalis Inc [Member]          
Disaggregation of Revenue [Line Items]          
Term of agreement 3 years        
Personalis Inc [Member] | Commercialization and Reference Laboratory Agreement Member With Personalis Inc [Member]          
Disaggregation of Revenue [Line Items]          
Aggregate milestone amount payable $ 12,000        
Contract with customer assets net current   $ 3,900   $ 4,700  
Personalis Inc [Member] | Commercialization and Reference Laboratory Agreement [Member]          
Disaggregation of Revenue [Line Items]          
Class Of Warrant Share Issued   9,218,800     9,218,800
One Year [Member] | Long-Term Contract with Customer [Member]          
Disaggregation of Revenue [Line Items]          
Revenue, remaining performance obligation, percentage   50.00%      
Two Year [Member] | Long-Term Contract with Customer [Member]          
Disaggregation of Revenue [Line Items]          
Revenue, remaining performance obligation, percentage   38.00%      
Three Year [Member] | Long-Term Contract with Customer [Member]          
Disaggregation of Revenue [Line Items]          
Revenue, remaining performance obligation, percentage   7.00%      
Four and Thereafter [Member] | Long-Term Contract with Customer [Member]          
Disaggregation of Revenue [Line Items]          
Revenue, remaining performance obligation, percentage   5.00%      
Genomics Product [Member] | Self-Pay [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from contract with customers excluding assessed tax   $ 21,800 12,300    
Clinical Order [Member] | Third-Party Payor [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from contract with customers excluding assessed tax   239,300 181,500    
Insights Product [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from contract with customers excluding assessed tax   71,300 49,500    
Trials Product [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from contract with customers excluding assessed tax   9,900 9,700    
Next Product [Member]          
Disaggregation of Revenue [Line Items]          
Revenue from contract with customers excluding assessed tax   $ 5,700 $ 2,700